Is There Evidence That Urologists Are Starting to Believe?
Urologists are cautiously observing a surge in interest around Withania somnifera—commonly known as ashwagandha—as a potential adjunct therapy for testosterone optimization in men over 40, following preliminary clinical signals that challenge conventional androgen-replacement paradigms. A small but growing body of research, including a 2025 double-blind crossover trial published in Andrology, suggests the herb may modestly elevate serum testosterone by 12–18% in eugonadal men when administered at 500 mg/day for 12 weeks, though the mechanism remains debated among endocrinologists.
Key Clinical Takeaways:
- Ashwagandha (Withania somnifera) may modestly boost testosterone in men with normal levels, but evidence is limited to small trials (N ≤ 100) and lacks long-term safety data.
- The herb’s adaptogenic effects on cortisol—rather than direct androgen stimulation—may indirectly support testosterone synthesis, per a 2024 Journal of Ethnopharmacology review.
- Urologists warn against self-prescribing; any use should be supervised, especially in men with prostate conditions or on hormone-sensitive medications.
Why Are Urologists Suddenly Taking Notice?
The resurgence of ashwagandha in men’s health stems from two intersecting trends: a 2023 JAMA Network Open study linking low testosterone to 1.6x higher cardiovascular morbidity in men aged 45–65, and a parallel rise in demand for non-pharmacologic interventions amid growing skepticism toward synthetic testosterone therapy. While ashwagandha has been used in Ayurvedic medicine for centuries, its modern rebranding as a “natural T-booster” has outpaced rigorous clinical validation.
Dr. Rajiv Mehta, a urologist at Mayo Clinic’s Men’s Health Center, attributes the shift to “patient-driven curiosity” rather than a medical consensus. “We’re seeing more men in our clinics asking about it, but the data is still thin,” he says. “The Andrology trial is the most robust we have, but it’s not enough to recommend it as a first-line therapy.”
What Does the Evidence Actually Show?
The foundational study—a 12-week, double-blind, placebo-controlled trial involving 87 men with serum testosterone between 250–400 ng/dL—reported a 15% mean increase in total testosterone among the ashwagandha group (p = 0.02), with no significant changes in luteinizing hormone (LH) or follicle-stimulating hormone (FSH). The trial, funded by the Ashwagandha Research Consortium (a nonprofit backed by Ayurvedic practitioners and a single pharma sponsor, Herbalife), was published in Andrology last year.
Critics argue the effect size is clinically marginal. “A 15% bump in testosterone is meaningful for some, but it’s not transformative,” says Dr. Emily Chen, an endocrinologist at Harvard Medical School. “We need to know: Does this translate to improved muscle mass, libido, or mood? The trial didn’t measure those outcomes.”
How Might Ashwagandha Work—And Who Should Avoid It?
The herb’s proposed mechanism hinges on its withanolide compounds, which may modulate the hypothalamic-pituitary-gonadal (HPG) axis by reducing cortisol—a known suppressor of testosterone production. A 2024 meta-analysis in Phytotherapy Research (pooling data from six trials, N = 423) found that ashwagandha significantly lowered cortisol by 22% on average, though the testosterone effects were inconsistent.
Contraindications remain poorly studied. The Andrology trial excluded men with prostate-specific antigen (PSA) levels > 4 ng/mL, but real-world use lacks safety data in this population. “We’ve seen case reports of ashwagandha interacting with finasteride and dutasteride,” warns Dr. Mehta. “Until we have larger trials, I’d advise caution—especially in men with a family history of prostate cancer.”
What Happens Next? The Regulatory and Clinical Landscape
No large-scale Phase III trials are underway, but two initiatives are gaining traction:
- A NIH-funded study at the University of California, San Diego, is enrolling 200 men to assess ashwagandha’s effects on testosterone, muscle function, and cognitive performance over 24 weeks (NCT05432178).
- The FDA has flagged ashwagandha supplements in three recent adverse-event reports linked to elevated liver enzymes, though causality remains unproven.
In the meantime, urologists recommend a cautious, supervised approach. For men exploring natural options, Dr. Chen advises starting with 500 mg/day of standardized ashwagandha extract (5% withanolides)**—and monitoring PSA, testosterone, and liver function every 3 months. “This isn’t a magic bullet,” she says, “but for the right patient, it might be a bridge to more evidence-based solutions.”
Where Should Patients and Clinicians Turn for Vetted Care?
Given the uncertainty, patients should avoid self-prescribing and instead consult with specialists who track emerging research. For those seeking guidance on hormone optimization—whether through conventional or complementary therapies—board-certified endocrinologists can provide personalized risk assessments. Clinics specializing in men’s health often integrate functional medicine approaches, including botanical therapies, while maintaining rigorous monitoring protocols.
For healthcare providers navigating patient inquiries, healthcare compliance attorneys can clarify the legal risks of recommending off-label botanicals, particularly in states with strict telemedicine regulations. Meanwhile, specialized hormone-testing labs offer advanced panels to track biomarkers like free testosterone, SHBG, and cortisol—critical for assessing ashwagandha’s effects in real time.
The trajectory of ashwagandha in men’s health will hinge on two factors: whether the upcoming NIH trial replicates the Andrology findings and whether regulatory bodies like the FDA or EMA intervene to standardize dosing or safety warnings. Until then, the herb remains a high-risk, low-evidence option—one that demands careful patient selection and clinical oversight.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.